NeoSync is committed to the advancement of research in this field, with completed, ongoing, and planned trials.  

advancing the treatment of Major depression through personalized Therapy

CAUTION: NEST® is an investigational device and limited by federal (United States) law to Investigational Use

NeoSync is a clinical-stage company with a proprietary platform technology being used to develop advanced, non-invasive neuromodulation products. 

Through our NEST® technology, we are pioneering personalized, low energy brain stimulation for the treatment of Major Depressive Disorder and other diseases of the Central Nervous System (CNS). 

Clinical

ReSEARCH